ChatGPT’s Agreement with the Recommendations from the 18th St. Gallen International Consensus Conference on the Treatment of Early Breast Cancer
2024

ChatGPT's Role in Breast Cancer Treatment Recommendations

Sample size: 71 publication 10 minutes Evidence: moderate

Author Information

Author(s): Nabieva Naiba, Brucker Sara Y., Gmeiner Benjamin, Papadimitriou Christos

Primary Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg

Hypothesis

Can ChatGPT support expert discussions in developing breast cancer treatment recommendations?

Conclusion

ChatGPT shows potential in developing breast cancer treatment recommendations, especially in areas with high agreement with expert panel responses.

Supporting Evidence

  • ChatGPT answered 71 out of 127 questions in accordance with the expert panel's most common answers.
  • The average reliability of ChatGPT's answers was 98.31% in cases where it agreed with the panel.
  • High agreement was observed in topics like Genetics and Well-being for breast cancer survivors.
  • ChatGPT's performance was less satisfactory in areas like Adjuvant endocrine therapy.

Takeaway

This study looked at how well ChatGPT can help doctors decide on breast cancer treatments, and it found that ChatGPT did a pretty good job in some areas.

Methodology

ChatGPT answered the same set of questions posed to a panel of experts at the St. Gallen International Breast Cancer Conference, and the agreement between responses was evaluated using statistical measures.

Potential Biases

The study's design may not fully capture the variability of expert opinions since ChatGPT provided consistent answers across multiple rounds.

Limitations

Some topics had very few questions, and ChatGPT did not have the option to abstain from answering, which may bias the results.

Participant Demographics

71 panelists from 27 countries participated in the St. Gallen International Breast Cancer Conference.

Statistical Information

P-Value

0.680

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244163

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication